We excel in understanding the interdependency between pricing, reimbursement, HTA and Negotiations. We reckon the difference amongst different market archetypes and work with you to generate strong payor-relevant evidence and communicate the value proposition of your product in payor-accessible language.


  • Pharmaco-epidemiological studies
  • Patient / caregiver reported outcomes
  • Registries
  • Data analytics & Statistics
  • Health Economic Modelling/Economic Evaluation
  • Real World Evidence
  • Systematic reviews
  • Meta-analysis/Network meta-analysis
  • Health Economic Modelling/ Economic Evaluation
  • Disease burden


  • Horizon scanning
  • PEST Analysis
  • Legislation and processes
  • HTA landscape and Payor needs
  • Stakeholder mapping
  • Disease awareness
  • Medical need assessment
  • Value driver assessment
  • Strategic pricing
  • Pricing & Reimbursement Analysis
  • Risk and Value driver assessment


  • Key Value Message Testing by stakeholder group
  • Roadmap for launch
  • Product positioning tailored to market needs
  • Value story development / Value strategy
  • Objection handling
  • Value Proposition Optimization


  • Health Technology Assessment (HTA)
  • Qualitative Price assessment
  • Innovative contracting
  • Scenario planning and options for managed entry agreements
  • Comparative HTA evidence and HTA strategy tailored to market needs
  • Environment shaping/preparation
  • Advocacy
  • Advisory Boards
  • Mock Negotiations
  • Delphi Panels